Chronic restraint stress-induced depression-like behavior is mediated by upregulation of melanopsin expression in C57BL/6 mice retina

Psychopharmacology (Berl). 2023 Feb;240(2):283-293. doi: 10.1007/s00213-022-06302-6. Epub 2022 Dec 29.

Abstract

Background: Depression is associated with circadian disturbances in which melanopsin was a key mechanism. Further studies have demonstrated that melanopsin gene variations are associated with some depressive disorders and aberrant light can impair mood through melanopsin-expressing retinal ganglion cells (mRGCs). The goal of this study was to explore the direct relationship between depression and melanopsin.

Methods: Adult C57BL/6 male mice were physically restrained for 16 h in a 50-ml polypropylene centrifuge tube and all behavioral tests were performed after CRS treatment. Western blot analysis and immunofluorescence were used to detect melanopsin expression in the retina of C57BL/6 mice. And we observed the change of the electrophysiological function and release of glutamate of mRGCs.

Results: The melanopsin expression upregulate in mRGCs of chronic restraint stress (CRS)-treating mice which exhibit depression-like behavior. The frequency of blue light-induced action potentials and light-induced glutamate release mediated by melanopsin also increase significantly. This change of melanopsin is mediated by the CRS-induced glucocorticoid.

Conclusions: CRS may induce the depression-like behavior in mice via glucocorticoid-melanopsin pathway. Our findings provide a novel mechanistic link between CRS-induced depression and melanopsin in mice.

Keywords: Chronic restraint stress; Depression; Glucocorticoid; Melanopsin; mRGCs.

MeSH terms

  • Animals
  • Depression* / etiology
  • Glucocorticoids* / metabolism
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Retina / metabolism
  • Up-Regulation

Substances

  • melanopsin
  • Glucocorticoids